Clinical Study
Bone Loss after Allogeneic Haematopoietic Stem Cell Transplantation: A Pilot Study on the Use of Zoledronic Acid
Figure 3
T-score (mean ± SD) of lumbar spine (a) and femur hip (b) after treatment with zoledronic acid.
|
(a) Lumbar spine: baseline −1.99 (±1.20), 1 year −1.41 (±1.49), 2 years −0.85 (±1.48) |
|
|
(b) Femur hip: baseline −1.88 (±0.83), 1 year −1.53 (±0.86), 2 years −1.18 (±0.70) |
|